产品详情
In vitro | DMSO | 83 mg/mL (169.57 mM) | |
Water | Insoluble | ||
Ethanol | 8 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.43 mL | 102.15 mL | 204.3 mL |
0.5 mM | 4.09 mL | 20.43 mL | 40.86 mL |
1 mM | 2.04 mL | 10.22 mL | 20.43 mL |
5 mM | 0.41 mL | 2.04 mL | 4.09 mL |
*The above data is based on the productmolecular weight 489.47. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A15062 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 489.47 |
Formula | C26H21F2N5O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1225278-16-9 |
Synonyms | DCC2618, DCC 2618 |
SMILES | CN1C=C(C=N1)C2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=CC=C5)F |
产品标签
Product Questions
Product Questions
Toceranib (PHA 291639, SU 11654)
Toceranib (PHA 291639,SU 11654)是一种激酶抑制剂,通过抑制KIT,血管内皮生长因子受体2和PDGFRβ同时具有抗肿瘤…
Crenolanib (CP-868596)
Crenolanib (CP-868596)是口服生物可用的PDGFR酪氨酸激酶的选择性小分子抑制剂,在皮摩尔浓度下抑制PDGFRA和PDGFR…
Masitinib mesylate
Masitinib mesylate是Kit和PDGFRα/β的新型抑制剂,IC50为200 nM和540 nM/800 nM,对ABL和c-Fms的抑制作用较弱。
Pazopanib HCl (GW786034)
Pazopanib HCl (GW786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可…